Ethanol extract of magnolia officinalis prevents lipopolysaccharide-induced memory deficiency via its antineuroinflammatory and antiamyloidogenic effects

Phytotherapy Research

Volumn 27, Issue 3, 2013, Pages 438-447

  Lee, Young Jung ^a   Choi, Dong Young ^a   Yun, Yeo Pyo ^a   Han, Sang Bae ^a   Kim, Hwan Mook ^b   Lee, Kiho ^c   Choi, Seok Hwa ^a   Yang, Mhan Pyo ^a   Jeon, Hyun Soo ^d   Jeong, Jea Hwang ^e   Oh, Ki Wan ^a   Hong, Jin Tae ^a  

^a Chungbuk National University   (South Korea)

^b Gachon University College of Medicine   (South Korea)

^c Korea University   (South Korea)

^d Konkuk University   (South Korea)

^e Chungbuk Provincial College   (South Korea)

Author keywords

amyloid; LPS; magnolia; Magnolia officinalis; neuroinflammation

Indexed keywords

AMYLOID PRECURSOR PROTEIN; BETA SECRETASE 1; CASPASE 3; CYCLOOXYGENASE 2; INDUCIBLE NITRIC OXIDE SYNTHASE; MAGNOLIA OFFICINALIS EXTRACT;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIAMYLOIDOGENIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTROCYTE; BARK; CELL ACTIVATION; CONTROLLED STUDY; DOWN REGULATION; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; IMMUNOHISTOCHEMISTRY; LATENT PERIOD; MALE; MICROGLIA; MOUSE; NERVE CELL NECROSIS; NONHUMAN; PASSIVE AVOIDANCE; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; UPREGULATION; WESTERN BLOTTING;

AMYLOID BETA-PROTEIN PRECURSOR; AMYLOIDOSIS; ANIMALS; ANTI-INFLAMMATORY AGENTS; ASTROCYTES; BRAIN; CYCLOOXYGENASE 2; INFLAMMATION; LIPOPOLYSACCHARIDES; MAGNOLIA; MALE; MEMORY DISORDERS; MICE; MICE, INBRED ICR; MICROGLIA; NITRIC OXIDE SYNTHASE TYPE II; PLANT BARK; PLANT EXTRACTS;

MAGNOLIA; MAGNOLIA OFFICINALIS;

EID: 84874933357     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.4740     Document Type: Article

References (83)

1. Akiyama H, Barger S, Barnum S, et al,. 2000. Inflammation and Alzheimer's disease. Neurobiol Aging 21: 383-421. (Pubitemid 30349107)
2. Bay-Richter C, Janelidze S, Hallberg L, Brundin L,. 2011. Changes in behaviour and cytokine expression upon a peripheral immune challenge. Behav Brain Res 222: 193-199.
3. Blennow K, de Leon MJ, Zetterberg H,. 2006. Alzheimer's disease. Lancet 368: 387-403. (Pubitemid 44108123)
4. Block ML, Zecca L, Hong JS,. 2007. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 8: 57-69. (Pubitemid 46011999)
5. Bluthe RM, Laye S, Michaud B, Combe C, Dantzer R, Parnet P,. 2000. Role of interleukin-1beta and tumour necrosis factor-alpha in lipopolysaccharide- induced sickness behaviour: a study with interleukin-1 type I receptor-deficient mice. Eur J Neurosci 12: 4447-4456. (Pubitemid 32037853)
6. Chen CL, Chang PL, Lee SS, Peng FC, Kuo CH, Chang HT,. 2007. Analysis of magnolol and honokiol in biological fluids by capillary zone electrophoresis. J Chromatogr A 1142: 240-244.
7. Cho HJ, Kim SK, Jin SM, et al,. 2007. IFN-gamma-induced BACE1 expression is mediated by activation of JAK2 and ERK1/2 signaling pathways and direct binding of STAT1 to BACE1 promoter in astrocytes. Glia 55: 253-262.
8. Choi IS, Lee YJ, Choi DY, et al,. 2011. 4-O-Methylhonokiol attenuated memory impairment through modulation of oxidative damage of enzymes involving amyloid-beta generation and accumulation in a mouse model of Alzheimer's disease. J Alzheimers Dis 27: 127-141.
9. Choi JH, Ha J, Park JH, et al,. 2002. Costunolide triggers apoptosis in human leukemia U937 cells by depleting intracellular thiols. Jpn J Cancer Res 93: 1327-1333. (Pubitemid 36104872)
10. Cui HS, Huang LS, Sok DE, et al,. 2007. Protective action of honokiol, administered orally, against oxidative stress in brain of mice challenged with NMDA. Phytomedicine 14: 696-700. (Pubitemid 47419299)
11. Dikalov S, Losik T, Arbiser JL,. 2008. Honokiol is a potent scavenger of superoxide and peroxyl radicals. Biochem Pharmacol 76: 589-596.
12. Fang F, Lue LF, Yan S, et al,. 2010. RAGE-dependent signaling in microglia contributes to neuroinflammation, Abeta accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease. FASEB J 24: 1043-1055.
13. Ferri CP, Sousa R, Albanese E, Ribeiro WS, Honyashiki M,. 2009. World Alzheimer report 2009-executive summary. 1-22.
14. Fujita S, Taira J,. 1994. Biphenyl compounds are hydroxyl radical scavengers: their effective inhibition for UV-induced mutation in Salmonella typhimurium TA102. Free Radic Biol Med 17: 273-277. (Pubitemid 24269680)
15. Goos M, Lange P, Hanisch UK, et al,. 2007. Fibronectin is elevated in the cerebrospinal fluid of patients suffering from bacterial meningitis and enhances inflammation caused by bacterial products in primary mouse microglial cell cultures. J Neurochem 102: 2049-2060. (Pubitemid 47329276)
16. Gunasingh MJ, Philip JE, Ashok BS, et al,. 2008. Melatonin prevents amyloid protofibrillar induced oxidative imbalance and biogenic amine catabolism. Life Sci 83: 96-102.
17. Guo JT, Yu J, Grass D, de Beer FC, Kindy MS,. 2002. Inflammation- dependent cerebral deposition of serum amyloid a protein in a mouse model of amyloidosis. J Neurosci 22: 5900-5909. (Pubitemid 35387634)
18. Hartlage-Rubsamen M, Zeitschel U, Apelt J, et al,. 2003. Astrocytic expression of the Alzheimer's disease beta-secretase (BACE1) is stimulus-dependent. Glia 41: 169-179. (Pubitemid 36262194)
19. Heneka MT, Kummer MP, Weggen S, et al,. 2011. Molecular mechanisms and therapeutic application of NSAIDs and derived compounds in Alzheimer's disease. Curr Alzheimer Res 8: 115-131.
20. Hensley K, Maidt ML, Yu Z, Sang H, Markesbery WR, Floyd RA,. 1998. Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation. J Neurosci 18: 8126-8132. (Pubitemid 28464991)
21. Hoi CP, Ho YP, Baum L, Chow AH,. 2010. Neuroprotective effect of honokiol and magnolol, compounds from Magnolia officinalis, on beta-amyloid-induced toxicity in PC12 cells. Phytother Res 24: 1538-1542.
22. Hou YC, Chao PD, Chen SY,. 2000. Honokiol and magnolol increased hippocampal acetylcholine release in freely-moving rats. Am J Chin Med 28: 379-384.
23. Hughes MM, Field RH, Perry VH, Murray CL, Cunningham C,. 2010. Microglia in the degenerating brain are capable of phagocytosis of beads and of apoptotic cells, but do not efficiently remove PrPSc, even upon LPS stimulation. Glia 58: 2017-2030.
24. Ito K, Iida T, Ichino K, Tsunezuka M, Hattori M, Namba T,. 1982. Obovatol and obovatal, novel biphenyl ether lignans from the leaves of Magnolia obovata Thunb. Chem Pharm Bull (Tokyo) 30: 3347-3353.
25. Iwasaki K, Wang Q, Seki H, et al,. 2000. The effects of the traditional Chinese medicine, "Banxia Houpo Tang (Hange-Koboku To)" on the swallowing reflex in Parkinson's disease. Phytomedicine 7: 259-263. (Pubitemid 30618489)
26. Jaeger LB, Dohgu S, Sultana R, et al,. 2009. Lipopolysaccharide alters the blood-brain barrier transport of amyloid beta protein: a mechanism for inflammation in the progression of Alzheimer's disease. Brain Behav Immun 23: 507-517.
27. Jeong HK, Jou I, Joe EH,. 2010. Systemic LPS administration induces brain inflammation but not dopaminergic neuronal death in the substantia nigra. Exp Mol Med 42: 823-832.
28. Kang JS, Lee KH, Han MH, et al,. 2008. Antiinflammatory activity of methanol extract isolated from stem bark of Magnolia kobus. Phytother Res 22: 883-888.
29. Kong CW, Tsai K, Chin JH, Chan WL, Hong CY,. 2000. Magnolol attenuates peroxidative damage and improves survival of rats with sepsis. Shock 13: 24-28.
30. Kuribara H, Stavinoha WB, Maruyama Y,. 1998. Behavioural pharmacological characteristics of honokiol, an anxiolytic agent present in extracts of Magnolia bark, evaluated by an elevated plus-maze test in mice. J Pharm Pharmacol 50: 819-826. (Pubitemid 28379279)
31. Lee JW, Lee YK, Ban JO, et al,. 2009a. Green tea (-)-epigallocatechin-3- gallate inhibits beta-amyloid-induced cognitive dysfunction through modification of secretase activity via inhibition of ERK and NF-kappaB pathways in mice. J Nutr 139: 1987-1993.
32. Lee JW, Lee YK, Lee BJ, et al,. 2010. Inhibitory effect of ethanol extract of Magnolia officinalis and 4-O-methylhonokiol on memory impairment and neuronal toxicity induced by beta-amyloid. Pharmacol Biochem Behav 95: 31-40.
33. Lee JW, Lee YK, Yuk DY, et al,. 2008. Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation. J Neuroinflammation 5: 37.
34. Lee YJ, Choi IS, Park MH, et al,. 2011a. 4-O-Methylhonokiol attenuates memory impairment in presenilin 2 mutant mice through reduction of oxidative damage and inactivation of astrocytes and the ERK pathway. Free Radic Biol Med 50: 66-77.
35. Lee YJ, Lee YM, Lee CK, Jung JK, Han SB, Hong JT,. 2011b. Therapeutic applications of compounds in the Magnolia family. Pharmacol Ther 130: 157-176.
36. Lee YK, Choi IS, Ban JO, et al,. 2011c. 4-O-methylhonokiol attenuated beta-amyloid-induced memory impairment through reduction of oxidative damages via inactivation of p38 MAP kinase. J Nutr Biochem 22: 476-486.
37. Lee YK, Yuk DY, Kim TI, et al,. 2009b. Protective effect of the ethanol extract of Magnolia officinalis and 4-O-methylhonokiol on scopolamine-induced memory impairment and the inhibition of acetylcholinesterase activity. J Nat Med 63: 274-282.
38. Lee YK, Yuk DY, Lee JW, et al,. 2009c. (-)-Epigallocatechin-3-gallate prevents lipopolysaccharide-induced elevation of beta-amyloid generation and memory deficiency. Brain Res 1250: 164-174.
39. Lin SP, Tsai SY, Lee Chao PD, Chen YC, Hou YC,. 2011. Pharmacokinetics, bioavailability, and tissue distribution of magnolol following single and repeated dosing of magnolol to rats. Planta Med 77: 1800-1805.
40. Lin YR, Chen HH, Ko CH, Chan MH,. 2006. Neuroprotective activity of honokiol and magnolol in cerebellar granule cell damage. Eur J Pharmacol 537: 64-69.
41. Lin YR, Chen HH, Ko CH, Chan MH,. 2007. Effects of honokiol and magnolol on acute and inflammatory pain models in mice. Life Sci 81: 1071-1078.
42. Luo L, Nong Wang J, Kong LD, Jiang QG, Tan RX,. 2000. Antidepressant effects of Banxia Houpu decoction, a traditional Chinese medicinal empirical formula. J Ethnopharmacol 73: 277-281.
43. Maeda J, Ji B, Irie T, et al,. 2007. Longitudinal, quantitative assessment of amyloid, neuroinflammation, and anti-amyloid treatment in a living mouse model of Alzheimer's disease enabled by positron emission tomography. J Neurosci 27: 10957-10968. (Pubitemid 47574168)
44. Mastronardi CA, Licinio J, Wong ML,. 2010. Candidate biomarkers for systemic inflammatory response syndrome and inflammation: a pathway for novel translational therapeutics. Neuroimmunomodulation 17: 359-368.
45. Matsui N, Takahashi K, Takeichi M, et al,. 2009. Magnolol and honokiol prevent learning and memory impairment and cholinergic deficit in SAMP8 mice. Brain Res 1305: 108-117.
46. Mattson MP, Maudsley S, Martin B,. 2004. A neural signaling triumvirate that influences ageing and age-related disease: insulin/IGF-1, BDNF and serotonin. Ageing Res Rev 3: 445-464. (Pubitemid 39487900)
47. McAlpine FE, Lee JK, Harms AS, et al,. 2009. Inhibition of soluble TNF signaling in a mouse model of Alzheimer's disease prevents pre-plaque amyloid-associated neuropathology. Neurobiol Dis 34: 163-177.
48. McGeer EG, McGeer PL,. 2003. Inflammatory processes in Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 27: 741-749. (Pubitemid 36966754)
49. McGeer PL, McGeer EG,. 2006. NSAIDs and Alzheimer disease: epidemiological, animal model and clinical studies. Neurobiol Aging 28: 639-647. (Pubitemid 46349357)
50. Michelucci A, Heurtaux T, Grandbarbe L, Morga E, Heuschling P,. 2009. Characterization of the microglial phenotype under specific pro-inflammatory and anti-inflammatory conditions: effects of oligomeric and fibrillar amyloid-beta. J Neuroimmunol 210: 3-12.
51. Morris R,. 1984. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 11: 47-60. (Pubitemid 14088970)
52. Munroe ME, Arbiser JL, Bishop GA,. 2007. Honokiol, a natural plant product, inhibits inflammatory signals and alleviates inflammatory arthritis. J Immunol 179: 753-763.
53. Nadler Y, Alexandrovich A, Grigoriadis N, et al,. 2008. Increased expression of the gamma-secretase components presenilin-1 and nicastrin in activated astrocytes and microglia following traumatic brain injury. Glia 56: 552-567.
54. Nguyen HN, Lee MS, Hwang DY, et al,. 2007. Mutant presenilin 2 increased oxidative stress and p53 expression in neuronal cells. Biochem Biophys Res Commun 357: 174-180. (Pubitemid 46591891)
55. Nichol KE, Poon WW, Parachikova AI, Cribbs DH, Glabe CG, Cotman CW,. 2008. Exercise alters the immune profile in Tg2576 Alzheimer mice toward a response coincident with improved cognitive performance and decreased amyloid. J Neuroinflammation 5: 13.
56. Ock J, Han HS, Hong SH, et al,. 2010. Obovatol attenuates microglia-mediated neuroinflammation by modulating redox regulation. Br J Pharmacol 159: 1646-1662.
57. Oh JH, Kang LL, Ban JO, et al,. 2009. Anti-inflammatory effect of 4-O-methylhonokiol, a novel compound isolated from Magnolia officinalis through inhibition of NF-kappaB. Chem Biol Interact 180: 506-514.
58. Paris D, Townsend KP, Obregon DF, Humphrey J, Mullan M,. 2002. Pro-inflammatory effect of freshly solubilized beta-amyloid peptides in the brain. Prostaglandins Other Lipid Mediat 70: 1-12.
59. Pratico D, Trojanowski JQ,. 2000. Inflammatory hypotheses: novel mechanisms of Alzheimer's neurodegeneration and new therapeutic targets? Neurobiol Aging 21: 441-445; discussion 451-443. (Pubitemid 30349112)
60. Qin L, Wu X, Block ML, et al,. 2007. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 55: 453-462. (Pubitemid 46383175)
61. Ransohoff RM, Perry VH,. 2009. Microglial physiology: unique stimuli, specialized responses. Annu Rev Immunol 27: 119-145.
62. Rodriguez JJ, Olabarria M, Chvatal A, Verkhratsky A,. 2009. Astroglia in dementia and Alzheimer's disease. Cell Death Differ 16: 378-385.
63. Sastre M, Dewachter I, Landreth GE, et al,. 2003. Nonsteroidal anti-inflammatory drugs and peroxisome proliferator-activated receptor-gamma agonists modulate immunostimulated processing of amyloid precursor protein through regulation of beta-secretase. J Neurosci 23: 9796-9804. (Pubitemid 37371592)
64. Scholtzova H, Kascsak RJ, Bates KA, et al,. 2009. Induction of toll-like receptor 9 signaling as a method for ameliorating Alzheimer's disease-related pathology. J Neurosci 29: 1846-1854.
65. Schubert D, Soucek T, Blouw B,. 2009. The induction of HIF-1 reduces astrocyte activation by amyloid beta peptide. Eur J Neurosci 29: 1323-1334.
66. Sheng JG, Bora SH, Xu G, Borchelt DR, Price DL, Koliatsos VE,. 2003. Lipopolysaccharide-induced-neuroinflammation increases intracellular accumulation of amyloid precursor protein and amyloid beta peptide in APPswe transgenic mice. Neurobiol Dis 14: 133-145. (Pubitemid 37103187)
67. Simic G, Lucassen PJ, Krsnik Z, et al,. 2000. nNOS expression in reactive astrocytes correlates with increased cell death related DNA damage in the hippocampus and entorhinal cortex in Alzheimer's disease. Exp Neurol 165: 12-26.
68. Song WZ, Cui JF, Zhang GD,. 1989. Studies on the medicinal plants of Magnoliaceae tu-hou-po of Manglietia. Yao Xue Xue Bao 24: 295-299.
69. Sparkman NL, Martin LA, Calvert WS, Boehm GW,. 2005. Effects of intraperitoneal lipopolysaccharide on Morris maze performance in year-old and 2-month-old female C57BL/6J mice. Behav Brain Res 159: 145-151. (Pubitemid 40410596)
70. Steward O, Torre ER, Tomasulo R, Lothman E,. 1991. Neuronal activity up-regulates astroglial gene expression. Proc Natl Acad Sci USA 88: 6819-6823. (Pubitemid 21915041)
71. Tachikawa E, Takahashi M, Kashimoto T,. 2000. Effects of extract and ingredients isolated from Magnolia obovata Thunberg on catecholamine secretion from bovine adrenal chromaffin cells. Biochem Pharmacol 60: 433-440. (Pubitemid 30336641)
72. Tarr AJ, McLinden KA, Kranjac D, Kohman RA, Amaral W, Boehm GW,. 2011. The effects of age on lipopolysaccharide-induced cognitive deficits and interleukin-1[beta] expression. Behav Brain Res 217: 481-485.
73. Tsai TH, Chou CJ, Chen CF,. 1996. Pharmacokinetics and brain distribution of magnolol in the rat after intravenous bolus injection. J Pharm Pharmacol 48: 57-59. (Pubitemid 26128686)
74. Vassar R,. 2001. The beta-secretase, BACE: a prime drug target for Alzheimer's disease. J Mol Neurosci 17: 157-170. (Pubitemid 33063520)
75. Veerhuis R,. 2011. Histological and direct evidence for the role of complement in the neuroinflammation of AD. Curr Alzheimer Res 8: 34-58.
76. Wang X, Duan X, Yang G, et al,. 2011. Honokiol crosses BBB and BCSFB, and inhibits brain tumor growth in rat 9L intracerebral gliosarcoma model and human U251 xenograft glioma model. PLoS One 6: e18490.
77. Wang Z, Li DD, Liang YY, Wang DS, Cai NS,. 2002. Activation of astrocytes by advanced glycation end products: cytokines induction and nitric oxide release. Acta Pharmacol Sin 23: 974-980. (Pubitemid 35285178)
78. Watanabe K, Watanabe H, Goto Y, Yamaguchi M, Yamamoto N, Hagino K,. 1983. Pharmacological properties of magnolol and honokiol extracted from Magnolia officinalis: central depressant effects. Planta Med 49: 103-108. (Pubitemid 14239052)
79. Weeks BS,. 2009. Formulations of dietary supplements and herbal extracts for relaxation and anxiolytic action: Relarian. Med Sci Monit 15: RA256-RA262.
80. Xu F, Grande AM, Robinson JK, et al,. 2007. Early-onset subicular microvascular amyloid and neuroinflammation correlate with behavioral deficits in vasculotropic mutant amyloid beta-protein precursor transgenic mice. Neuroscience 146: 98-107. (Pubitemid 46654629)
81. Xu Q, Yi LT, Pan Y, et al,. 2008. Antidepressant-like effects of the mixture of honokiol and magnolol from the barks of Magnolia officinalis in stressed rodents. Prog Neuropsychopharmacol Biol Psychiatry 32: 715-725. (Pubitemid 351312371)
82. Yan SD, Bierhaus A, Nawroth PP, Stern DM,. 2009. RAGE and Alzheimer's disease: a progression factor for amyloid-beta-induced cellular perturbation? J Alzheimers Dis 16: 833-843.
83. Zhou HY, Shin EM, Guo LY, et al,. 2008. Anti-inflammatory activity of 4-methoxyhonokiol is a function of the inhibition of iNOS and COX-2 expression in RAW 264.7 macrophages via NF-kappaB, JNK and p38 MAPK inactivation. Eur J Pharmacol 586: 340-349.